Strategic Partnership between AKTOR Group and the Institute for Neurovascular Innovationfor a Three-Year Postdoctoral Fellowship at Stanford University School of Medicine
We are delighted and honored to announce the first fellowship secured by the Institute for Neurovascular Innovation , made possible through the generous support of AKTOR Group.
The three-year fellowship will support a Neurosurgery Resident who will participate in the research and educational program of the Department of Neurosurgery at Stanford University School of Medicine as a Visiting Postdoctoral Scholar.
The Institute for Neurovascular Innovation extends its deepest appreciation and sincere gratitude to the company’s management for its immediate and positive response to the request to fund this fellowship. This initiative will enable the Fellow to spend three years at one of the world’s leading academic institutions, developing advanced expertise in Experimental Neuroscience and Neurosurgery.
Investing in Young Scientists, Securing the Future of Healthcare
As part of its multifaceted Corporate Social Responsibility strategy, AKTOR Group maintains a strong commitment to major contributions in healthcare, educational programs, and infrastructure projects with significant social impact.
Its partnership with the Institute for Neurovascular Innovation is a tangible reflection of the Group’s commitment to supporting scientific excellence. At the same time, it contributes to advancing research into the prevention and treatment of arteriovenous malformations of the central nervous system and cerebrovascular diseases, as well as the mechanisms of neurorehabilitation following vascular injury.
Statement by the President of the Institute, Mr. Ioannis Foteinos:
“At a time when specialized education and international training opportunities for young physicians require substantial resources, the Institute for Neurovascular Innovation is building lasting bridges between the scientists of tomorrow and the business community.
Our goal is to provide the next generation of healthcare professionals with the resources and opportunities they need to advance their knowledge and expertise. AKTOR Group’s generous support represents an outstanding example of corporate social responsibility and investment in scientific progress—an investment whose ultimate beneficiaries are society and the people we serve.”
